Therapy Areas: Devices
Azenta completes of Barkey acquisition
4 July 2022 -

Azenta, Inc. (Nasdaq: AZTA), a US-based provider of life sciences solutions worldwide, announced on Friday that it has completed its acquisition of Barkey Holding GmbH and its subsidiaries, a Germany-based company that provides controlled rate thawing devices for customers in the medical, biotech and pharmaceutical industries.

This move is intended to extend Azenta's cold chain capabilities and improves its reach with customers across all phases of development, discovery and commercialisation.

Barkey has more than four decades of expertise in the automated thawing of plasma, blood and stem cells and has an established footprint in the large and growing cell and gene therapy market.